Real-World Clinical and Economic Outcomes Associated with Surgiflo^® vs Floseal in Cardiovascular Surgeries in the US

References

• Abubakar I, Tilmann T, Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171.
   PubMed Web of Science ®Google Scholar
• Ali M, Beusenberg M, Bloessner M. World health statistics; 2009. Available from: https://www.who.int/gho/publications/world_health_statistics/EN_WHS09_Full.pdf. Accessed February 1, 2022.
   Google Scholar
• Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–2619. doi:10.1093/eurheartj/ehu278
   PubMed Web of Science ®Google Scholar
• Chang M, Ahn JM, Lee CW, et al. Long-term mortality after coronary revascularization in nondiabetic patients with multivessel disease. J Am Coll Cardiol. 2016;68(1):29–36. doi:10.1016/j.jacc.2016.04.034
   PubMed Web of Science ®Google Scholar
• Verma K, Errico TJ, Vaz KM, Lonner BS. A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery. BMC Surg. 2010;10:13. doi:10.1186/1471-2482-10-13
   PubMed Web of Science ®Google Scholar
• Hassan N, Halanski M, Wincek J, et al. Blood management in pediatric spinal deformity surgery: review of a 2-year experience. Transfusion. 2011;51(10):2133–2141. doi:10.1111/j.1537-2995.2011.03175.x
   PubMed Web of Science ®Google Scholar
• Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg. 2001;93(1):82–87. doi:10.1097/00000539-200107000-00018
   PubMed Web of Science ®Google Scholar
• Boldt J, Schindler E, Osmer CH, Wittstock M, Stertmann WA, Hempelmann G. Influence of different anticoagulation regimens on platelet function during cardiac surgery. Br J Anaesth. 1994;73(5):639–644. doi:10.1093/bja/73.5.639
   PubMed Web of Science ®Google Scholar
• Gravlee GP, Scott Haddon W, Rothberger HK, et al. Heparin dosing and monitoring for cardiopulmonary bypass: a comparison of techniques with measurement of subclinical plasma coagulation. J Thorac Cardiovasc Surg. 1990;99(3):518–527. doi:10.1016/S0022-5223(19)36983-1
   PubMed Web of Science ®Google Scholar
• Williams JB, Phillips-Bute B, Bhattacharya SD, et al. Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2011;141(5):1283–1288. doi:10.1016/j.jtcvs.2010.07.098
   PubMed Web of Science ®Google Scholar
• Kinnunen EM, De Feo M, Reichart D, et al. Incidence and prognostic impact of bleeding and transfusion after coronary surgery in low‐risk patients. Transfusion. 2017;57(1):178–186. doi:10.1111/trf.13885
   PubMed Web of Science ®Google Scholar
• Généreux P, Cohen DJ, Williams MR, et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014;63(11):1100–1109. doi:10.1016/j.jacc.2013.10.058
   PubMed Web of Science ®Google Scholar
• Beverly A, Ong G, Wilkinson KL, Doree C, Welton NJ, Estcourt LJ. Drugs to reduce bleeding and transfusion in adults undergoing cardiac surgery: a systematic review and network meta‐analysis. Cochrane Database Syst Rev. 2019;2019(9). doi:10.1002/14651858.CD013427
   Google Scholar
• Al-Attar N, Johnston S, Jamous N, et al. Impact of bleeding complications on length of stay and critical care utilization in cardiac surgery patients in England. J Cardiothorac Surg. 2019;14(1):64. doi:10.1186/s13019-019-0881-3
   PubMed Web of Science ®Google Scholar
• Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg. 2009;88(5):1520–1526. doi:10.1016/j.athoracsur.2009.07.014
   PubMed Web of Science ®Google Scholar
• Tackett SM, Calcaterra D, Magee G, Lattouf OM. Real-world outcomes of hemostatic matrices in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28(6):1558–1565. doi:10.1053/j.jvca.2014.05.010
   PubMed Web of Science ®Google Scholar
• Oz MC, Cosgrove DM, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg. 2000;69(5):1376–1382. doi:10.1016/S0003-4975(00)01194-2
   PubMed Web of Science ®Google Scholar
• Woodworth BA, Chandra RK, LeBenger JD, Ilie B, Schlosser RJ. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery. Am J Otolaryngol. 2009;30(1):49–53. doi:10.1016/j.amjoto.2007.11.008
   PubMed Web of Science ®Google Scholar
• Vyas KS, Saha SP. Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther. 2013;13(12):1663–1672. doi:10.1517/14712598.2013.848193
   PubMed Web of Science ®Google Scholar
• Makhija D, Rock M, Ikeme S, et al. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients. J Med Econ. 2017;20(6):606–613. doi:10.1080/13696998.2017.1292916
   PubMed Web of Science ®Google Scholar
• Premier Applied Sciences® PI. Premier healthcare database white paper: data that informs and perform; 2019. Available from: https://learn.premierinc.com/white-papers/premier-healthcaredatabase-whitepaper. Accessed February 1, 2022.
   Google Scholar
• Ballinger GA. Using generalized estimating equations for longitudinal data analysis. Organ Res Methods. 2004;7(2):127–150. doi:10.1177/1094428104263672
   Web of Science ®Google Scholar
• Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–494. doi:10.1016/S0167-6296(01)00086-8
   PubMed Web of Science ®Google Scholar
• Renkens KL, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976). 2001;26(15):1645–1650. doi:10.1097/00007632-200108010-00002
   PubMed Web of Science ®Google Scholar
• Weaver FA, Hood DB, Zatina M, Messina L, Badduke B. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg. 2002;16(3):286–293. doi:10.1007/s10016-001-0073-0
   PubMed Web of Science ®Google Scholar
• Gill IS, Ramani AP, Spaliviero M, et al. Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant. Urology. 2005;65(3):463–466. doi:10.1016/j.urology.2004.10.030
   PubMed Web of Science ®Google Scholar